Biotechnology fermenting across all regions

Biotechnology fermenting across all regions

(April 4, 2008) Twenty-one percent of biotechnology organisations are active in the Auckland region, but biotechnology activity is spread evenly across the remainder of the country, Statistics New Zealand said today.  These figures are from the Biotechnology Survey 2007, which measures the use of biotechnologies and their uptake by organisations, and includes regional figures for the first time in the biennial survey's history.

Of the biotechnology techniques used by New Zealand organisations in 2007, 67 percent were at the research and development (R&D) stage. The predominant technique used in the R&D stage was DNA sequencing/synthesis/amplification.

The most common constraint to biotechnology R&D was lack of access to capital, reported by 50 percent of organisations active in biotechnology.

In the two years to June 2007, 225 biotechnology-related patents were granted to New Zealand organisations. Of these patents, the private sector was responsible for the most patents (108), followed by the public sector (75), and the higher education sector (48).

Statistics New Zealand will not be releasing information gathered in the 2007 survey for the areas relating to income, expenditure, exports and employment at this time. We will be reviewing the biotechnology survey data quality and methodology to determine the best approach for future releases.

Geoff Bascand
Government Statistician 4 April 2008

END

For media information contact:
Andrew Hunter
Wellington 04 931 4600
Email: [email protected]

Suggested Articles

Almirall and Iktos will use the latter's AI technology to design new compounds that tick multiple drug criteria boxes.

Pfizer’s 2017 spinout company SpringWorks has lost president and founder Lara Sullivan, M.D., who has moved over to Pyxis Oncology as its new chief.

In this week's EuroBiotech Report, Sanofi inks $2.5B Synthorx takeover and posts sutimlimab data, Roche shares bispecific results and more.